Panelists discuss how real-world data on the incidence of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) compare with clinical trial findings as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback